Ensysce Biosciences, Inc.
ENSC
$0.25
$0.000.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.18M | -10.97M | -6.58M | -6.82M | -7.99M |
| Total Depreciation and Amortization | 6.50K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 25.70K | 1.20M |
| Total Other Non-Cash Items | 847.60K | 453.30K | 373.10K | 142.00K | 138.40K |
| Change in Net Operating Assets | 1.52M | 3.47M | 9.80K | 846.30K | -851.30K |
| Cash from Operations | -7.81M | -7.04M | -6.20M | -5.80M | -7.50M |
| Capital Expenditure | -123.60K | -123.60K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -123.60K | -123.60K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -216.30K | -207.60K | -239.00K | -266.10K | -857.80K |
| Issuance of Common Stock | 3.67M | 3.35M | 3.52M | 3.48M | 4.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 3.98M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.31M | 1.55M | 4.09M | 2.24M | 6.64M |
| Cash from Financing | 8.74M | 4.69M | 7.37M | 5.45M | 9.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 808.20K | -2.48M | 1.17M | -351.80K | 2.38M |